Association between copeptin and declining glomerular filtration rate in people with newly diagnosed diabetes. The Skaraborg Diabetes Register

Journal of Diabetes and Its Complications
M PikkemaatK Bengtsson Boström

Abstract

Copeptin has shown association with development of chronic kidney disease (CKD) in people with diabetes. Early detection of individuals having the highest risk could help avoid this complication. Therefore we decided to study copeptin concentrations and estimated glomerular filtration rate (eGFR) retrospectively in people with newly diagnosed diabetes. People with newly diagnosed type 2 diabetes in 1996-1998 from Skaraborg Diabetes Register (SDR) were reinvestigated in 2008-2010. Copeptin concentration at the time of diagnosis was determined. Creatinine and cystatin C were used for determination of eGFR at baseline and at reinvestigation (n=161). Data on cardiovascular complications were extracted from national registers. Analyzes were done with logistic regression. From baseline to follow up eGFR decreased with 33ml. Twenty-nine individuals (18.1%) developed CKD stage 3. There was a significant association between elevated copeptin concentrations and development of CKD stage 3 (OR=1.78, 95% CI=1.01-3.16). When adjusting for GFR at baseline the association between copeptin and GFR decline was borderline significant (OR=1.79, 95% CI=0.99-3.25, p=0.055). Determination of copeptin may early identify people with diabetes and high r...Continue Reading

Associated Clinical Trials

References

Nov 5, 2005·Clinical Chemistry·Nils G MorgenthalerAndreas Bergmann
Feb 8, 2008·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
May 5, 2010·Circulation·Sofia EnhörningOlle Melander
Apr 15, 2011·The Journal of Clinical Endocrinology and Metabolism·Sofia EnhörningOlle Melander
Jun 11, 2011·BMC Public Health·Jonas F LudvigssonPetra Otterblad Olausson
Nov 30, 2011·Scandinavian Journal of Clinical and Laboratory Investigation·Anders GrubbJonas Björk
Jan 21, 2012·Current Opinion in Endocrinology, Diabetes, and Obesity·David W Lam, Derek LeRoith
Apr 24, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Wendy E BoertienRon T Gansevoort
May 23, 2012·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S EnhörningO Melander
Aug 3, 2012·The Journal of Clinical Endocrinology and Metabolism·Wiebke Fenske, Bruno Allolio
Nov 3, 2012·International Journal of Hypertension·Maguy ChihaEdgar G Chedrawy
Aug 22, 2014·International Ophthalmology·Grete GarbergKristina Bengtsson Boström
Oct 10, 2014·Acta Diabetologica·Giuseppe Pugliese
Oct 30, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·M PikkemaatK B Boström

❮ Previous
Next ❯

Citations

Jul 3, 2016·Diabetes Research and Clinical Practice·Ralf SchielGünter Stein
Apr 14, 2017·Current Opinion in Nephrology and Hypertension·Ronan RousselLise Bankir
Feb 23, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sofia EnhörningOlle Melander
Mar 10, 2018·Diabetologia·Helen M Colhoun, M Loredana Marcovecchio
Jul 18, 2018·BioMed Research International·Katarzyna CzarzastaStanisław Niemczyk
May 28, 2019·BMC Endocrine Disorders·M PikkemaatE L Strandberg
Jul 22, 2018·Endocrine·Giovanna MuscogiuriSilvia Savastano
Oct 28, 2019·Reviews in Endocrine & Metabolic Disorders·Mirjam Christ-Crain
Feb 26, 2019·F1000Research·Marianna RanieriGiovanna Valenti
Feb 3, 2021·Acta Diabetologica·Federica BaruttaGabriella Gruden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.